Stockreport

Century Therapeutics Announces New Beta Islet Program for Type 1 Diabetes

Century Therapeutics, Inc.  (IPSC) 
PDF Allo-Evasion™ 5.0-engineered iPSC beta islets are designed to overcome immune rejection and provide durable glucose control without chronic immunosuppressionCompelling p [Read more]